Carmustine and Back pain aggravated - a phase IV clinical study of FDA data

Summary:

Back pain aggravated is reported as a side effect among people who take Carmustine (carmustine), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Cytoxan, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Back pain aggravated when taking Carmustine. It is created by eHealthMe based on reports of 4,562 people who have side effects when taking Carmustine from the FDA, and is updated regularly.

What is Carmustine?

Carmustine has active ingredients of carmustine. eHealthMe is studying from 4,562 Carmustine users. Check the latest studies of Carmustine.

What is Back pain aggravated?

Back pain aggravated is found to be associated with 3,366 drugs and 2,097 conditions by eHealthMe. Check the latest studies of Back pain aggravated.

On Jul, 21, 2026

4,562 people reported to have side effects when taking Carmustine.
Among them, 19 people (0.42%) have Back pain aggravated.

Could Carmustine cause Back pain aggravated?

Among these 19 people:

How long have people been on Carmustine when they have Back pain aggravated? *

What is the gender of people who have Back pain aggravated when taking Carmustine? *

female: 77.78 %
male: 22.22 %

What is the age of people who have Back pain aggravated when taking Carmustine? *

What are other drugs people take besides Carmustine? *

What are other side effects people have besides Back pain aggravated? *

Chest Pain: 11 people, 57.89%
Disease Progression: 10 people, 52.63%
Dyspnea (difficult or laboured breathing): 9 people, 47.37%
Pain In Extremity: 9 people, 47.37%
Myocardial Ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased): 9 people, 47.37%
Cerebral Arteriosclerosis (thickening and hardening of the walls of the arteries in the brain): 8 people, 42.11%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 8 people, 42.11%
Head Discomfort: 8 people, 42.11%
Presbyopia (a condition in which the lens of the eye loses its ability to focus, making it difficult to see objects up close): 8 people, 42.11%
Pathogen Resistance: 8 people, 42.11%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 10 people, 52.63%
Mycosis Fungoides (lymphocytes (a type of white blood cell) become malignant (cancerous) and affect the skin): 3 people, 15.79%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 5.26%
Non-Hodgkin's Lymphoma Stage Iv (malignant (cancer) cells form in the lymph system- stageiv): 1 person, 5.26%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 1 person, 5.26%
Neuropathic Pain (pain due to nerve inflammation and damage): 1 person, 5.26%
Neoplasm Malignant (cancer tumour): 1 person, 5.26%
Central Nervous System Lymphoma (cancer of central nervous system forms in lymph tissue): 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Carmustine and have Back pain aggravated?

- Check whether Back pain aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Carmustine:

Carmustine (4,562 reports)

Browse all side effects of Carmustine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Back pain aggravated:

Back pain aggravated (3,366 drugs)

Browse all the conditions that are associated with Back pain aggravated:

Back pain aggravated (2,097 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on carmustine (the active ingredients of Carmustine) and Carmustine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.